LT 0011

Drug Profile

LT 0011

Alternative Names: Lecithin-modified superoxide dismutase - LTT Bio-Pharma; LT-0011; PC-SOD; PC-SOD NE; Recombinant midismase - LTT Bio-Pharma

Latest Information Update: 18 May 2016

Price : $50

At a glance

  • Originator LTT Bio-Pharma
  • Class Anti-inflammatories; Anti-ischaemics; Oxidoreductases
  • Mechanism of Action Antioxidants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Interstitial lung diseases
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Interstitial lung diseases; Ulcerative colitis
  • Phase I Idiopathic pulmonary fibrosis

Most Recent Events

  • 15 Jun 2015 Phase-II development is ongoing for idiopathic interstitial pneumonia and ulcerative colitis in Japan
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top